{"id":"velmanase","brandName":"velmanase","genericName":"velmanase","companyId":"unknown","companyName":"","phase":"unknown","status":"active","modality":"","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"","enrichmentLevel":3,"visitCount":0,"mechanism":{},"administration":{},"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":["NCT06184503","NCT02998879","NCT04031066","NCT04959240"],"indications":{"approved":[{"name":"Alpha-mannosidosis","diseaseId":"alpha-mannosidosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[{"nctId":"NCT06184503","phase":"N/A","title":"A Real-world Analysis of Pharmacodynamic Response to Velmanase Alfa (Lamzede®) Treatment in Patients With Alpha-Mannosidosis Less Than 3 Years of Age","status":"RECRUITING","sponsor":"Chiesi Farmaceutici S.p.A.","isPivotal":false,"enrollment":5,"indication":"Alpha-Mannosidosis","completionDate":"2029-09"},{"nctId":"NCT02998879","phase":"Phase 2","title":"A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years o","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","isPivotal":false,"enrollment":5,"indication":"Alpha-Mannosidosis","completionDate":"2020-07"},{"nctId":"NCT04031066","phase":"Phase 3","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis","status":"WITHDRAWN","sponsor":"Chiesi Farmaceutici S.p.A.","isPivotal":true,"enrollment":0,"indication":"Alpha-Mannosidosis","completionDate":"2021-12-29"},{"nctId":"NCT04959240","phase":"N/A","title":"","status":"AVAILABLE","sponsor":"Chiesi Farmaceutici S.p.A.","isPivotal":false,"enrollment":0,"indication":"Alpha-Mannosidosis","completionDate":""}],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}